- Markets were in a wait and see mode ahead of last night’s interest rate decision from the US Federal Reserve.
- In an incremental positive for Sanofi, Dupixent has been approved by the EC as the first and only targeted medicine indicated for prurigo nodularis, a chronic extremely itchy skin disorder. It is already approved for the condition in the US.
- US bond yields moved marginally higher yesterday.
Overview
Investment Solutions
Pension Solutions
SDIO
Application Forms – Intermediaries
Creating impact for your clients, their financial goals, and their future
Overview
Focused on your organisation, funding its growth, and unlocking its full potential
Debt Capital Markets
Probate Services
Dedicated to institutional wealth, stakeholder value, and a sustainable future
Overview
Investment Services
Stewardship
Supportive of you, your custodial vision, and your philanthropic goals
X